ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,830.75
0.06%
Gold vs US Dollar
2,420.535
-0.24%
Brent Oil
82.365
-1.39%
Bitcoin
70,034.85
-1.96%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. BiondVax Pharmaceuticals Ltd (BVXV) Share Price

BVXV BiondVax Pharmaceuticals Ltd

1.36
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 BiondVax Pharmaceuticals Ltd NASDAQ:BVXV NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 1.36 1.23 1.38 0.00 0.00   00:00:00   
 Type  Size  Price  Time  Units 
   0.00  
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore BVXV News
30/04/202421:06EDGAR2Form NT 20-F - Notification of inability to timely file Form 20-F
16/04/202422:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
10/04/202412:00PRNUSScinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMG
12/03/202420:17EDGAR2Form SC 13D - General statement of acquisition of beneficial ownership
12/03/202412:00PRNUSScinai leadership to attend BIO-Europe Spring 2024
13/02/202412:00PRNUSScinai Welcomes Liat Halpert as Head of Business Development and Sales
04/01/202421:01PRNUSScinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
16/08/202108:41PBBBiondvax7
Data Downloads for BVXV

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest BiondVax Pharmaceuticals Ltd Articles